For these reasons, while PSMA has its place in detecting PCa, PSMA PET/CT and/or PSMA PET/mpMRI may have limited benefit in the PI‐RADS framework, especially given the different roles each plays in PCa management for their respective patient populations. The gene discussed is FOLH1; the disease is posterior cortical atrophy.